PortfoliosLab logoPortfoliosLab logo
LRCX vs. ALAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LRCX vs. ALAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lam Research Corporation (LRCX) and Astera Labs, Inc. (ALAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LRCX achieves a 71.50% return, which is significantly lower than ALAB's 87.08% return.


LRCX

1D
-1.58%
1M
-25.11%
6M
25.75%
YTD
71.50%
1Y
210.67%
3Y*
61.40%
5Y*
37.09%
10Y*
43.64%
ALL TIME*
23.67%

ALAB

1D
3.85%
1M
-27.77%
6M
106.63%
YTD
87.08%
1Y
127.62%
3Y*
5Y*
10Y*
ALL TIME*
112.28%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.26B$1.54B$1.91B
$3.65B$3.82B$3.92B

LRCX vs. ALAB - Yearly Performance Comparison


2026 (YTD)20252024
LRCX
Lam Research Corporation
71.50%139.16%-21.80%
ALAB
Astera Labs, Inc.
87.08%25.60%152.00%

Correlation

The correlation between LRCX and ALAB is 0.50, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.50

Correlation (All Time)
Calculated using the full available price history since Mar 20, 2024

0.51

The correlation between LRCX and ALAB has been stable across timeframes, ranging from 0.50 to 0.51 - a consistent structural relationship.

Fundamentals

Market Cap

LRCX:

$366.44B

ALAB:

$53.35B

EPS

LRCX:

$5.75

ALAB:

$1.48

PE Ratio

LRCX:

50.95

ALAB:

210.48

PS Ratio

LRCX:

15.93

ALAB:

56.25

PB Ratio

LRCX:

29.63

ALAB:

37.74

Total Revenue (TTM)

LRCX:

$23.23B

ALAB:

$1.00B

Gross Profit (TTM)

LRCX:

$11.73B

ALAB:

$760.99M

EBITDA (TTM)

LRCX:

$8.70B

ALAB:

$253.12M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LRCX vs. ALAB — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LRCX
LRCX Risk / Return Rank: 9696
Overall Rank
LRCX Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
LRCX Sortino Ratio Rank: 9494
Sortino Ratio Rank
LRCX Omega Ratio Rank: 9393
Omega Ratio Rank
LRCX Calmar Ratio Rank: 9595
Calmar Ratio Rank
LRCX Martin Ratio Rank: 9898
Martin Ratio Rank

ALAB
ALAB Risk / Return Rank: 7979
Overall Rank
ALAB Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
ALAB Sortino Ratio Rank: 8080
Sortino Ratio Rank
ALAB Omega Ratio Rank: 7979
Omega Ratio Rank
ALAB Calmar Ratio Rank: 8080
Calmar Ratio Rank
ALAB Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LRCX vs. ALAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lam Research Corporation (LRCX) and Astera Labs, Inc. (ALAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LRCXALABDifference
Sharpe ratioReturn per unit of total volatility

+2.10

Sortino ratioReturn per unit of downside risk

+1.28

Omega ratioGain probability vs. loss probability

1.42

1.26

+0.16

Calmar ratioReturn relative to maximum drawdown

5.08

2.13

+2.95

Martin ratioReturn relative to average drawdown

21.44

4.03

+17.41

LRCX vs. ALAB - Sharpe Ratio Comparison

The current LRCX Sharpe Ratio is 3.37, which is higher than the ALAB Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of LRCX and ALAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LRCX vs. ALAB - Drawdown Comparison

The maximum LRCX drawdown since its inception was -87.90%, which is greater than ALAB's maximum drawdown of -63.69%. Use the drawdown chart below to compare losses from any high point for LRCX and ALAB.


Loading charts...

Drawdown Indicators


LRCXALABDifference

Max Drawdown

Largest peak-to-trough decline

-87.90%

-63.69%

-24.21%

Max Drawdown (1Y)

Largest decline over 1 year

-41.76%

-60.19%

+18.43%

Max Drawdown (3Y)

Largest decline over 3 years

-47.10%

Max Drawdown (5Y)

Largest decline over 5 years

-56.39%

Max Drawdown (10Y)

Largest decline over 10 years

-56.39%

Current Drawdown

Current decline from peak

-32.38%

-35.57%

+3.19%

Average Drawdown

Average peak-to-trough decline

-28.13%

-29.00%

+0.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.87%

31.79%

-21.92%

Volatility

LRCX vs. ALAB - Volatility Comparison

The current volatility for Lam Research Corporation (LRCX) is 27.34%, while Astera Labs, Inc. (ALAB) has a volatility of 34.17%. This indicates that LRCX experiences smaller price fluctuations and is considered to be less risky than ALAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LRCXALABDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.34%

34.17%

-6.83%

Volatility (6M)

Calculated over the trailing 6-month period

52.39%

77.73%

-25.34%

Volatility (1Y)

Calculated over the trailing 1-year period

63.10%

100.79%

-37.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.97%

95.32%

-46.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

46.20%

95.32%

-49.12%

Dividends

LRCX vs. ALAB - Dividend Comparison

LRCX's dividend yield for the trailing twelve months is around 0.35%, while ALAB has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ALAB
Astera Labs, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LRCX
Lam Research Corporation
0.35%0.57%1.19%0.95%1.53%0.78%1.04%1.54%2.79%1.01%1.28%1.36%

Financials

LRCX vs. ALAB - Financials Comparison

This section allows you to compare key financial metrics between Lam Research Corporation and Astera Labs, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

LRCX vs. ALAB - Profitability Comparison

The chart below illustrates the profitability comparison between Lam Research Corporation and Astera Labs, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

LRCX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Lam Research Corporation reported a gross profit of 3.48B and revenue of 6.72B. Therefore, the gross margin over that period was 51.8%.

ALAB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Astera Labs, Inc. reported a gross profit of 235.14M and revenue of 308.36M. Therefore, the gross margin over that period was 76.3%.

LRCX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Lam Research Corporation reported an operating income of 2.51B and revenue of 6.72B, resulting in an operating margin of 37.4%.

ALAB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Astera Labs, Inc. reported an operating income of 61.83M and revenue of 308.36M, resulting in an operating margin of 20.1%.

LRCX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Lam Research Corporation reported a net income of 2.28B and revenue of 6.72B, resulting in a net margin of 33.9%.

ALAB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Astera Labs, Inc. reported a net income of 80.31M and revenue of 308.36M, resulting in a net margin of 26.0%.


Frequently Asked Questions


LRCX and ALAB have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ALAB has higher volatility (34.17%) compared to LRCX (27.34%). In terms of maximum drawdown, LRCX dropped -87.90% vs ALAB's -63.69%.

LRCX currently has the higher Sharpe Ratio (3.37 vs 1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LRCX and ALAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer